A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)

NCT07700758 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Neoplasm

Interventions

DRUG: Belzutifan

Sponsor

Merck Sharp & Dohme LLC